ID   FH21
AC   CVCL_E607
DR   dbMHC; 48795
DR   IHW; IHW09403
DR   IPD-IMGT/HLA; 26007
DR   Wikidata; Q54834809
RX   PubMed=30844424;
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*02:30,03:01:01:01; B*35:01:01:02,38:01:01; C*04:01:01,12:03:01:01; DPA1*01:03:01:03,01:03:01:04; DPB1*03:01:01,04:01:01:01; DQA1*01:01:01,01:03:01:02; DQB1*05:01:01:02,06:03:01; DRB1*01:01:01,13:01:01 (IPD-IMGT/HLA=26007).
CC   HLA typing: A*02:30:01,03:01:01:01; B*38:01:01,35:01:01:02; C*04:01:01:01,12:03:01:01; DPA1*01:03:01:03,01:03:01:04; DPB1*03:01:01(124:01),04:01:01:01(350:01); DQA1*01:03:01,01:01:01; DQB1*06:03:01,05:01:01:03; DRB1*13:01:01,01:01:01; DRB3*01:01:02 (PubMed=30844424).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 16
//
RX   PubMed=30844424; DOI=10.1016/j.humimm.2019.03.001; PMCID=PMC6599558;
RA   Creary L.E., Guerra S.G., Chong W., Brown C.J., Turner T.R.,
RA   Robinson J., Bultitude W.P., Mayor N.P., Marsh S.G.E., Saito K.,
RA   Lam K., Duke J.L., Mosbruger T.L., Ferriola D., Monos D.S., Willis A.,
RA   Askar M., Fischer G.F., Saw C.L., Ragoussis J., Petrek M.,
RA   Serra-Pages C., Juan Otero M., Stavropoulos-Giokas C., Dinou A., Ameen R.,
RA   Al Shemmari S., Spierings E., Gendzekhadze K., Morris G.P., Zhang Q.-H.,
RA   Kashi Z., Hsu S., Gangavarapu S., Mallempati K.C., Yamamoto F.,
RA   Osoegawa K., Vayntrub T., Chang C.-J., Hansen J.A.,
RA   Fernandez-Vina M.A.;
RT   "Next-generation HLA typing of 382 International Histocompatibility
RT   Working Group reference B-lymphoblastoid cell lines: report from the
RT   17th International HLA and Immunogenetics Workshop.";
RL   Hum. Immunol. 80:449-460(2019).
//